您好, 歡迎來(lái)到智慧城市網(wǎng)! 登錄| 免費(fèi)注冊(cè)| 產(chǎn)品展廳| 收藏商鋪|
行業(yè)產(chǎn)品
當(dāng)前位置:廣州健侖生物科技有限公司>>生物試劑>>Certest>> 西班牙Certest溶組織內(nèi)阿米巴重組蛋白
參 考 價(jià) | 面議 |
產(chǎn)品型號(hào)西班牙
品 牌
廠商性質(zhì)生產(chǎn)商
所 在 地廣州市
更新時(shí)間:2022-11-29 15:00:59瀏覽次數(shù):619次
聯(lián)系我時(shí),請(qǐng)告知來(lái)自 智慧城市網(wǎng)西班牙Certest溶組織內(nèi)阿米巴重組蛋白
廣州健侖生物科技有限公司
廣州健侖長(zhǎng)期供應(yīng)各種生物原料,主要代理品牌:西班牙Certest。
主要產(chǎn)品包括各種生物單克隆抗原抗體、重組蛋白。
西班牙Certest溶組織內(nèi)阿米巴重組蛋白
我司還提供其它進(jìn)口或國(guó)產(chǎn)試劑盒:登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團(tuán)菌、化妝品檢測(cè)、食品安全檢測(cè)等試劑盒以及日本生研細(xì)菌分型診斷血清、德國(guó)SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。
歡迎咨詢
歡迎咨詢2042552662
【產(chǎn)品介紹】
貨號(hào) | 產(chǎn)品名稱 | 規(guī)格 | 英文名稱 |
MT-18EH30 | 阿米巴原蟲抗體(克隆H30) | x1mg | Anti-Entamoeba Mab (clone EH30) |
MT-25ETV | 腸道病毒VP1重組蛋白 | x1mg | Enterovirus VP1 recombinant protein |
MT-18EV5 | 腸道病毒抗體(克隆EV5) | x1mg | Anti-Enterovirus Mab (clone EV5) |
MT-25STX | 大腸桿菌O157 VT1重組蛋白 | x1mg | E. coli O157 VT1 recombinant protein |
MT-25VT2 | 大腸桿菌O157 VT2重組蛋白 | x1mg | E. coli O157 VT2 recombinant protein |
MT-18E10 | 大腸桿菌O157抗體(克隆E10) | x1mg | Anti-E. coli O157 Mab (clone E10) |
MT-18SN3 | 肺炎鏈球菌單克隆抗體(克隆SN3) | x1mg | Anti-Streptococcus pneumoniae Mab (clone SN3) |
MT-18SN4 | 肺炎鏈球菌單克隆抗體(克隆SN4) | x1mg | Anti-Streptococcus pneumoniae Mab (clone SN4) |
MT-16CP14 | 鈣結(jié)合蛋白單克隆抗體(克隆CP14) | x1mg | Anti-Calprotectin Mab (clone CP14) |
MT-18RV3 | 呼吸道合胞病毒單抗(克隆RV3) | x1mg | Anti-RSV Mab (clone RV3) |
MT-18RV4 | 呼吸道合胞病毒單抗(克隆RV4) | x1mg | Anti-RSV Mab (clone RV4) |
MT-25RSV | 呼吸道合胞病毒重組融合蛋白 | x1mg | RSV recombinant fusion protein |
MT-18Y77 | 甲型流感病毒單抗(克隆Y77) | x1mg | Anti-Influenza A Mab (clone Y77) |
MT-25FAN | 甲型流感病毒重組核蛋白 | x1mg | Influenza A recombinant nucleoprotein |
MT-16G18 | 賈第鞭毛蟲抗體(克隆G18) | x1mg | Anti-Giardia Mab trophozoite protein (clone G18) |
MT-16G22 | 賈第鞭毛蟲抗體(克隆G22) | x1mg | Anti-Giardia Mab trophozoite protein (clone G22) |
MT-25A1G | 賈第蟲腸道滋養(yǎng)體重組蛋白 | x1mg | Giardia intestinalis trophozoite recombinant protein |
MT-25GCP | 賈第蟲腸囊菌重組蛋白 | x1mg | Giardia intestinalis cyst recombinant protein |
MT-25GDH | 艱難梭菌GDH重組蛋白 | x1mg | Clostridium difficile GDH recombinant protein |
MT-18TA5 | 艱難梭菌毒素A抗(克隆TA5) | x1mg | Anti-CD Toxin A Mab (clone TA5) |
MT-18TA7 | 艱難梭菌毒素A抗(克隆TA7) | x1mg | Anti-CD Toxin A Mab (clone TA7) |
MT-24TXA | 艱難梭菌毒素A重組蛋白(無(wú)毒性片段) | x1mg | C. difficile Toxin A recombinant protein (fragment without toxic activity) |
MT-18TB41 | 艱難梭菌毒素B抗(克隆TB41) | x1mg | Anti-CD Toxin B Mab (clone TB41) |
MT-18TB48 | 艱難梭菌毒素B抗(克隆TB48) | x1mg | Anti-CD Toxin B Mab (clone TB48) |
MT-24TXB | 艱難梭菌毒素B重組蛋白(無(wú)毒性片段) | x1mg | C. difficile Toxin B recombinant protein (fragment without toxic activity) |
MT-16GD10 | 艱難梭菌抗體(克隆GD10) | x1mg | Anti-GDH Mab (clone GD10) |
MT-25CEP | 空腸彎曲桿菌重組外膜蛋白 | x1mg | Campylobacter jejuni recombinant outer membrane protein |
MT-26VP6 | 輪狀病毒VP6重組蛋白 | x1mg | Rotavirus VP6 recombinant protein |
MT-16R15 | 輪狀病毒單克隆抗體(克隆R15) | x1mg | Anti-Rotavirus Mab (clone R15) |
MT-28SAGU | 滅活A(yù)鏈球菌抗原(天然提取物) | x1mg | Inactivated STREP A antigen (native extract) |
MT-28SEU | 滅活腸炎沙門氏菌抗原(天然提取物) | x1mg | Inactivated Salmonella enteritidis antigen (native extract) |
MT-28SBU | 滅活的鮑氏志賀氏菌抗原(天然提取物) | x1mg | Inactivated Shigella boydii antigen (native extract) |
MT-28EC7U | 滅活的大腸桿菌O157抗原(天然提取物) | x1mg | Inactivated E. coli O157 antigen (native extract) |
MT-28CCU | 滅活的大腸桿菌抗原(天然提取物) | x1mg | Inactivated Campylobacter coli antigen (native extract) |
MT-28LMU | 滅活的單核細(xì)胞增生李斯特菌抗原(天然提取物) | x1mg | Inactivated Listeria monocytogenes antigen (native extract) |
MT-28SPNU | 滅活的肺炎鏈球菌抗原(天然提取物) | x1mg | Inactivated Streptococcus pneumoniae antigen (native extract) |
MT-28SFU | 滅活的福氏志賀氏菌抗原(天然提取物) | x1mg | Inactivated Shigella flexneri antigen (native extract) |
MT-28CJU | 滅活的空腸彎曲桿菌抗原(天然提取物) | x1mg | Inactivated Campylobacter jejuni antigen (native extract) |
MT-28SDU | 滅活的痢疾志賀氏菌抗原(天然提取物) | x1mg | Inactivated Shigella dysenteriae antigen (native extract) |
MT-28LNU | 滅活的嗜肺軍團(tuán)菌抗原(天然提取物) | x1mg | Inactivated Legionella pneumophila antigen (native extract) |
MT-28STMU | 滅活的鼠傷寒沙門氏菌抗原(天然提取物) | x1mg | Inactivated Salmonella typhimurium antigen (native extract) |
MT-28SSU | 滅活的宋內(nèi)氏志賀菌抗原(天然提取物) | x1mg | Inactivated Shigella sonnei antigen (native extract) |
MT-28PECU | 滅活的幽門螺桿菌抗原(天然提取物) | x1mg | Inactivated H. pylori antigen (native extract) |
MT-29RVV | 滅活呼吸道合胞病毒抗原(天然提取物) | x1mg | Inactivated RSV antigen (native extract) |
MT-28SPAU | 滅活沙門氏菌副傷寒A抗原(天然提取物) | x1mg | Inactivated Salmonella paratyphi A antigen (native extract) |
MT-28SPBU | 滅活沙門氏菌副傷寒B抗原(天然提取物) | x1mg | Inactivated Salmonella paratyphi B antigen (native extract) |
MT-28STU | 滅活傷寒沙門氏菌抗原(天然提取物) | x1mg | Inactivated Salmonella typhi antigen (native extract) |
MT-28YE3U | 滅活小腸結(jié)腸炎耶爾森氏菌O:3抗原(天然提取物) | x1mg | Inactivated Yersinia enterocolitica O:3 antigen (native extract) |
MT-28YE9U | 滅活小腸結(jié)腸炎耶爾森氏菌O:9抗原(天然提取物) | x1mg | Inactivated Yersinia enterocolitica O:9 antigen (native extract) |
MT-29KOE | 滅活小球隱孢子蟲抗原(天然提取物) | x1mg | Inactivated Cryptosporidium parvum antigen (native extract) |
MT-25EDP | 內(nèi)阿米巴重組蛋白 | x1mg | Entamoeba dispar recombinant protein |
MT-25NGI1 | 諾如病毒GI.1重組P結(jié)構(gòu)域 | x1mg | Norovirus GI.1 recombinant P domain |
MT-31NGA | 諾如病毒GI.1重組VLP | x1mg | Norovirus GI.1 recombinant VLP |
MT-25NGI3 | 諾如病毒GI.3重組P結(jié)構(gòu)域 | x1mg | Norovirus GI.3 recombinant P domain |
MT-25NGII10 | 諾如病毒GII.10重組P結(jié)構(gòu)域 | x1mg | Norovirus GII.10 recombinant P domain |
MT-25NGII17 | 諾如病毒GII.17重組P結(jié)構(gòu)域 | x1mg | Norovirus GII.17 recombinant P domain |
MT-25NGII14 | 諾如病毒GII.4重組P結(jié)構(gòu)域 | x1mg | Norovirus GII.4 recombinant P domain |
MT-31NPA | 諾如病毒GII.4重組VLP | x1mg | Norovirus GII.4 recombinant VLP |
MT-18NP8 | 諾如病毒GII單克隆抗體(克隆NP8) | x1mg | Anti-Norovirus GII Mab (clone NP8) |
MT-18NG28 | 諾如病毒GI單克隆抗體(克隆NG28) | x1mg | Anti-Norovirus GI Mab (clone NG28) |
MT-25HCP | 人類鈣衛(wèi)蛋白重組蛋白 | x1mg | Human Calprotectin recombinant protein |
MT-29HLF | 人乳鐵蛋白蛋白質(zhì)(天然提取物) | x1mg | Human Lactoferrin protein (native extract) |
MT-29HHB | 人血紅蛋白蛋白質(zhì)(天然提取物) | x1mg | Human Haemoglobin protein (native extract) |
MT-29HTF | 人轉(zhuǎn)鐵蛋白蛋白質(zhì)(天然提取物) | x1mg | Human Transferrin protein (native extract) |
MT-20TSS | 溶血性A鏈球菌抗體 | x1mg | Anti-Strep A Pab |
MT-25EHP | 溶組織內(nèi)阿米巴重組蛋白 | x1mg | Entamoeba histolytica recombinant protein |
MT-16LC16 | 乳鐵蛋白單抗(克隆LC16) | x1mg | Anti-Lactoferrin Mab (clone LC16) |
MT-16LC4 | 乳鐵蛋白單抗(克隆LC4) | x1mg | Anti-Lactoferrin Mab (clone LC4) |
MT-18LN14 | 嗜肺軍團(tuán)菌單抗(克隆LN14) | x1mg | Anti-Legionella pneumophila Mab (clone LN14) |
MT-18LN29 | 嗜肺軍團(tuán)菌單抗(克隆LN29) | x1mg | Anti-Legionella pneumophila Mab (clone LN29) |
MT-16CA29 | 彎曲桿菌抗體(克隆ECA29) | x1mg | Anti-Campylobacter Mab (clone CA29) |
MT-25CCP | 彎曲桿菌重組外膜蛋白 | x1mg | Campylobacter coli recombinant outer membrane protein |
MT-25HEX | 腺病毒HEXON重組蛋白 | x1mg | Adenovirus HEXON recombinant protein |
MT-18A14 | 腺病毒單克隆抗體(克隆A14) | x1mg | Anti-Adenovirus Mab (clone A14) |
MT-18A15 | 腺病毒單克隆抗體(克隆A15) | x1mg | Anti-Adenovirus Mab (clone A15) |
MT-18A15 | 腺病毒抗體(克隆A15) | x1mg | Anti-Adenovirus Mab (clone A15) |
MT-25HEXR | 腺病毒六鄰體重組蛋白 | x1mg | Adenovirus HEXON recombinant protein |
MT-18AT18 | 星狀病毒單克隆抗體(克隆AT18) | x1mg | Anti-Astrovirus Mab (clone AT18) |
MT-18AT8 | 星狀病毒單克隆抗體(克隆AT8) | x1mg | Anti-Astrovirus Mab (clone AT8) |
MT-25AST | 星狀病毒衣殼重組蛋白 | x1mg | Astrovirus capsid recombinant protein |
MT-16F22 | 血紅蛋白單抗(克隆F22) | x1mg | Anti-Haemoglobin Mab (clone F22) |
MT-18YB91 | 乙型流感病毒單抗(克隆YB91) | x1mg | Anti-Influenza B Mab (clone YB91) |
MT-25FBN | 乙型流感病毒重組核蛋白 | x1mg | Influenza B recombinant nucleoprotein |
MT-18K31 | 隱球菌抗體(克隆K31) | x1mg | Anti-Crypto Mab (clone K31) |
MT-25PCH | 幽門螺桿菌重組外膜蛋白 | x1mg | H. pylori recombinant outer membrane protein |
MT-16P2 | 幽門螺旋桿菌抗體(克隆P2)HP抗體 | x1mg | Anti-H. pylori Mab (clone P2) |
西班牙
加拿大麥吉爾大學(xué)喬西·尤西尼-西格爾主持的新研究表明,p66ShcA蛋白富含于經(jīng)歷了上皮間質(zhì)細(xì)胞轉(zhuǎn)移的抗原抗體癌中。在所有抗原抗體癌類型中,p66ShcA表達(dá)水平的升高與上皮間質(zhì)細(xì)胞轉(zhuǎn)化基因的表達(dá)密切相關(guān)。因此,p66ShcA可用作確定各種分子亞型抗原抗體癌預(yù)后的*標(biāo)記。
抗原抗體癌至少有5種亞型,其中每一種都與不同預(yù)后結(jié)果相關(guān)。早期研究表明,亞型具有異質(zhì)性,因此基于亞型的預(yù)后結(jié)果不太可靠。研究人員表示,對(duì)造成腫瘤細(xì)胞異質(zhì)性和轉(zhuǎn)移基本機(jī)制的深入了解,有助于更好地明確疾病的預(yù)后發(fā)展并提出改善治療效果的方法。
盡管科學(xué)界對(duì)腦卒中的認(rèn)識(shí)和治療有著顯著進(jìn)步,但開發(fā)新型和有效的治療方式以對(duì)抗這種疾病仍然是一個(gè)主要的臨床問題。由腦卒中引起的神經(jīng)組織損傷是因?yàn)檠鞯酱竽X的中斷造成的,并導(dǎo)致葡萄糖,氧和其他營(yíng)養(yǎng)成分的缺乏。這會(huì)導(dǎo)致梗塞核心快速壞死,并形成缺血半影。這種半影可在亞急性期接受干預(yù)治療。在眾多的神經(jīng)變性途徑中,氧化應(yīng)激已被證明可加劇中樞神經(jīng)系統(tǒng)中次級(jí)細(xì)胞死亡。
DJ-1是一種多功能氧化還原敏感蛋白,與氧化應(yīng)激的細(xì)胞死亡級(jí)聯(lián)相關(guān)。DJ-1提供的神經(jīng)保護(hù)形式可通過(guò)多種途徑防止細(xì)胞死亡,zui重要的是通過(guò)降低線粒體氧化應(yīng)激和PD聚集蛋白α-突觸核蛋白分子陪伴(作用),以及刺激抗凋亡和抗氧化基因的表達(dá),促進(jìn)促生存Akt通路從而阻止細(xì)胞凋亡信號(hào)調(diào)節(jié)激酶(ASK1)途徑,并正調(diào)節(jié)雄激素受體依賴性轉(zhuǎn)錄。在細(xì)胞質(zhì)和細(xì)胞核中常見的是,DJ-1可被分泌到病理狀態(tài)下的血清中,還可以通過(guò)有絲分裂原刺激轉(zhuǎn)位到各種哺乳動(dòng)物細(xì)胞的線粒體中,特別令人感興趣的是,氧化應(yīng)激。
來(lái)自美國(guó)南佛羅里達(dá)大學(xué)醫(yī)學(xué)院Cesar V. Borlongan教授所在團(tuán)隊(duì)討論了其zui近發(fā)現(xiàn)的測(cè)試,DJ-1不僅可以作為氧化應(yīng)激的細(xì)胞內(nèi)保護(hù)的一種形式,也利用它從旁分泌和/或自分泌線索以完成相鄰神經(jīng)細(xì)胞之間的細(xì)胞外信號(hào)傳導(dǎo)從而達(dá)到神經(jīng)保護(hù)作用。相關(guān)研究?jī)?nèi)容發(fā)表在2014年8月第15期《中國(guó)神經(jīng)再生研究(英文版)》雜志上。
發(fā)表于2014年9月16日的《eLife》的新研究中,紐約大學(xué)朗格尼醫(yī)學(xué)中心和其他地方的科學(xué)家*報(bào)告了,一種叫做翻譯延伸因子eEF1A1的蛋白掌管了熱休克反應(yīng)的整個(gè)過(guò)程。通過(guò)這樣做,eEF1A1支持細(xì)胞內(nèi)的總蛋白的動(dòng)態(tài)平衡,確保其在各種內(nèi)部和外部的壓力條件下正常運(yùn)轉(zhuǎn)。研究人員表明,這項(xiàng)發(fā)現(xiàn)有可能揭示一個(gè)有前途的、新的用于神經(jīng)退行性疾病和癌癥的藥物靶標(biāo)。
西班牙
想了解更多的產(chǎn)品及服務(wù)請(qǐng)掃描下方二維碼:
【公司名稱】 廣州健侖生物科技有限公司
【市場(chǎng)部】 楊永漢
【】
【騰訊 】 2042552662
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號(hào)二期2幢101-103室
New research led by Josie Ussini-Siegel of McGill University in Canada shows that the p66ShcA protein is enriched in antigen-antibody cancers that have undergone epithelial mesenchymal cell metastasis. In all antigen-antibody cancer types, the increased expression of p66ShcA is closely related to the expression of epithelial-derived stromal cells. Therefore, p66ShcA can be used as a first choice marker for determining the prognosis of various molecular subtype antigens.
Antigen Antibody The cancer has at least 5 subtypes, each of which is associated with a different outcome. Early studies have shown that subtypes are heterogeneous, so prognosis based on subtypes is less reliable. The researchers said that an in-depth understanding of the underlying mechanisms responsible for tumor cell heterogeneity and metastasis can help to better define the prognosis of the disease and suggest ways to improve the outcome.
Despite significant advances in the understanding and treatment of stroke in the scientific community, developing new and effective treatments to combat the disease remains a major clinical problem. Nerve tissue damage caused by stroke is caused by a breakdown of blood flow to the brain and results in a lack of glucose, oxygen and other nutrients. This can lead to rapid necrosis of the infarct core and the formation of ischemic penumbra. This penumbra can be sub-acute intervention in the treatment. Among numerous neurodegeneration pathways, oxidative stress has been shown to exacerbate secondary cell death in the central nervous system.
DJ-1 is a multifunctional redox-sensitive protein that is associated with a cascade of oxidative stress. The neuroprotective forms provided by DJ-1 can prevent cell death through a variety of pathways, most importantly by reducing the mitochondrial oxidative stress and the complication of PD-aggregate alpha-synuclein molecules, as well as stimulating anti-apoptotic and anti- Oxidative gene expression promotes the pro-survival Akt pathway thus blocking the apoptotic signal-regulated kinase (ASK1) pathway and upregulating androgen receptor-dependent transcription. It is common in the cytoplasm and nucleus that DJ-1 can be secreted into the serum under pathological conditions and can also be stimulated to translocate to the mitochondria of various mammalian cells by mitogens. Of particular interest is the oxidation of Stress.
The team from Professor Cesar V. Borlongan, University of South Florida School of Medicine, USA, discussed his recently discovered test that DJ-1 can be used not only as a form of intracellular protection of oxidative stress, but also from paracrine and / or Secretion of clues to complete the extracellular signal transduction between adjacent nerve cells to achieve neuroprotective effect. Relevant research is published in the 15th issue of "Chinese Journal of Nervous Regeneration Research (English Edition)" in August 2014.
In a new study, "eLife," published September 16, 2014, scientists at New York University's Langley Medical Center and elsewhere first reported that a protein called the translation elongation factor eEF1A1 governs the entire course of the heat shock response . By doing so, eEF1A1 supports the homeostasis of total protein in the cell and ensures its normal operation under a variety of internal and external stress conditions. Researchers have shown that the discovery is likely to reveal a promising new drug target for neurodegenerative diseases and cancer.
請(qǐng)輸入賬號(hào)
請(qǐng)輸入密碼
請(qǐng)輸驗(yàn)證碼
以上信息由企業(yè)自行提供,信息內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),智慧城市網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。
溫馨提示:為規(guī)避購(gòu)買風(fēng)險(xiǎn),建議您在購(gòu)買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。